Phase 2 RAS-mutated Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 2

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

MCRCMSS Metastatic Colorectal CancerRas-mutated Metastatic Colorectal Cancer

Oncolytics Biotech60 enrolled3 locationsNCT07446322

Recruiting

Phase 1Phase 2

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

Non-small Cell Lung Cancer (NSCLC)KRAS, NRAS, HRAS-mutated NSCLCKRAS G12C-mutated Solid Tumors, Lung Cancer+2 more

Revolution Medicines, Inc.616 enrolled89 locationsNCT06162221

Recruiting

Phase 2

XELOX +Bev +Tislelizumab for First-line Treatment of MSS/pMMR RAS-mutated mCRC

CapecitabineTislelizumabMetastatic Colorectal Cancer (Mcrc)+5 more

Cancer Institute and Hospital, Chinese Academy of Medical Sciences52 enrolled1 locationNCT05970302